EA201390755A1 - БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПРОИЗВОДСТВА - Google Patents

БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПРОИЗВОДСТВА

Info

Publication number
EA201390755A1
EA201390755A1 EA201390755A EA201390755A EA201390755A1 EA 201390755 A1 EA201390755 A1 EA 201390755A1 EA 201390755 A EA201390755 A EA 201390755A EA 201390755 A EA201390755 A EA 201390755A EA 201390755 A1 EA201390755 A1 EA 201390755A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pi3k
methods
petroxazepins
manufacture
mtor inhibitors
Prior art date
Application number
EA201390755A
Other languages
English (en)
Inventor
Кеннет Райс
Original Assignee
Экселиксис, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Экселиксис, Инк. filed Critical Экселиксис, Инк.
Publication of EA201390755A1 publication Critical patent/EA201390755A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретение относится к ингибиторам PI3K и mTOR и их фармацевтически приемлемым солям или сольватам, а также способам их применения, в которых используются ингибиторы структурной формулы Iи их фармацевтически приемлемые соли, где переменные имеют значения, определенные в описании.
EA201390755A 2010-11-24 2011-11-23 БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПРОИЗВОДСТВА EA201390755A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41714210P 2010-11-24 2010-11-24
PCT/US2011/062029 WO2012074869A1 (en) 2010-11-24 2011-11-23 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture

Publications (1)

Publication Number Publication Date
EA201390755A1 true EA201390755A1 (ru) 2013-11-29

Family

ID=45217715

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390755A EA201390755A1 (ru) 2010-11-24 2011-11-23 БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПРОИЗВОДСТВА

Country Status (11)

Country Link
US (1) US20140005172A1 (ru)
EP (1) EP2643319A1 (ru)
JP (1) JP2013544827A (ru)
KR (1) KR20140000706A (ru)
CN (1) CN103402999A (ru)
AU (1) AU2011336882A1 (ru)
CA (1) CA2818882A1 (ru)
EA (1) EA201390755A1 (ru)
MX (1) MX2013005819A (ru)
WO (1) WO2012074869A1 (ru)
ZA (1) ZA201303758B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011302196B2 (en) 2010-09-14 2016-04-28 Exelixis, Inc. Inhibitors of PI3K-delta and methods of their use and manufacture
AU2012332486A1 (en) 2011-11-01 2014-06-19 Arthur Decillis N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies
TWI597061B (zh) * 2013-02-20 2017-09-01 國鼎生物科技股份有限公司 治療白血病之方法及組成物
PT3762368T (pt) 2018-03-08 2022-05-06 Incyte Corp Compostos de aminopirazina diol como inibidores de pi3k-y
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
WO2020124397A1 (en) * 2018-12-19 2020-06-25 Inventisbio Shanghai Ltd. C-terminal src kinase inhibitors
CN118201896A (zh) * 2021-09-10 2024-06-14 传达治疗有限公司 PI3K-α抑制剂和其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8044062B2 (en) * 2005-10-07 2011-10-25 Exelixis, Inc. Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alpha
EP2123644B1 (en) * 2007-03-07 2014-12-17 Takeda Pharmaceutical Company Limited Benzoxazepine derivatives and use thereof
WO2010118208A1 (en) * 2009-04-09 2010-10-14 Exelixis, Inc. Benzoxazepin-4- (5h) -yl derivatives and their use to treat cancer
KR20120034666A (ko) * 2009-05-22 2012-04-12 엑셀리시스, 인코포레이티드 증식성 질환에 대한 벤족사제핀 기반 ｐ１３ｋ／ｍｔ０ｒ의 억제제
WO2010135568A1 (en) * 2009-05-22 2010-11-25 Exelixis, Inc. Benzoxazepines as inhibitors of mtor and their use to treat cancer
AU2010254200A1 (en) * 2009-05-26 2011-12-08 Exelixis, Inc. Benzoxazepines as inhibitors of PI3K/m TOR and methods of their use and manufacture
CN103459384A (zh) * 2010-11-24 2013-12-18 埃克塞里艾克西斯公司 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用和制造方法

Also Published As

Publication number Publication date
EP2643319A1 (en) 2013-10-02
MX2013005819A (es) 2013-08-27
WO2012074869A1 (en) 2012-06-07
US20140005172A1 (en) 2014-01-02
CN103402999A (zh) 2013-11-20
AU2011336882A1 (en) 2013-06-20
JP2013544827A (ja) 2013-12-19
KR20140000706A (ko) 2014-01-03
ZA201303758B (en) 2014-04-30
WO2012074869A8 (en) 2013-07-18
CA2818882A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
CY1122266T1 (el) Ενωσεις 3-αμινοκυκλοαλκυλιου ως ror-gamma-t αναστολεις και χρησεις αυτων
EA201390766A1 (ru) БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
EA201590748A1 (ru) Противовирусные соединения против rsv
EA201491672A1 (ru) Гетероциклильные соединения как ингибиторы mek
EA201490971A1 (ru) Производные урацила в качестве ингибиторов axl и c-met киназы
WO2012068106A3 (en) Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
EA201491623A1 (ru) Замещенные пирролидин-2-карбоксамиды
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201790202A1 (ru) Фталазиноны и изохинолиноны в качестве ингибиторов rock
EA202090291A3 (ru) Производные бипиразола в качестве ингибиторов jak
EA201491247A1 (ru) Производные дигидробензооксазина и дигидропиридооксазина
WO2012068096A3 (en) Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
EA201190227A1 (ru) Оксазолзамещенные индазолы в качестве ингибиторов pi3-киназ
EA201400412A1 (ru) ЗАМЕЩЕННЫЕ БЕНЗИЛИНДАЗОЛЫ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Bub1 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
UA111770C2 (uk) Інгібітори бромдомену
EA201492216A1 (ru) Ингибиторы бромодомена и их применение
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
EA201390579A1 (ru) Производные хиназолин-4(3h)-она, используемые как ингибиторы pi3-киназы
UA111075C2 (uk) Триазолопіридинові сполуки як інгібітори кінази рім
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
EA201290880A1 (ru) Новые соединения - ингибиторы фермента
EA201301130A1 (ru) Имидазопиридазины в качестве ингибиторов акт киназы
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao